378 related articles for article (PubMed ID: 31811882)
1. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of the hepatitis C testing, care and treatment program in the country of Georgia's corrections system, December 2013 - April 2015.
Harris AM; Chokoshvili O; Biddle J; Turashvili K; Japaridze M; Burjanadze I; Tsertsvadze T; Sharvadze L; Karchava M; Talakvadze A; Chakhnashvili K; Demurishvili T; Sabelashvili P; Foster M; Hagan L; Butsashvili M; Morgan J; Averhoff F
BMC Public Health; 2019 May; 19(Suppl 3):466. PubMed ID: 32326938
[TBL] [Abstract][Full Text] [Related]
3. Lessons Learned From Global Hepatitis C Elimination Programs.
Handanagic S; Shadaker S; Drobeniuc J; Tsereteli M; Alkhazashvili M; Adesigbin C; Adamu I; Adabe R; Agwuocha C; Adisa O; Azania A; Boeke CE; Ngwije A; Serumondo J; Armstrong PA
J Infect Dis; 2024 May; 229(Supplement_3):S334-S341. PubMed ID: 37739781
[TBL] [Abstract][Full Text] [Related]
4. The Role of Screening and Treatment in National Progress Toward Hepatitis C Elimination - Georgia, 2015-2016.
Nasrullah M; Sergeenko D; Gvinjilia L; Gamkrelidze A; Tsertsvadze T; Butsashvili M; Metreveli D; Sharvadze L; Alkhazashvili M; Shadaker S; Ward JW; Morgan J; Averhoff F
MMWR Morb Mortal Wkly Rep; 2017 Jul; 66(29):773-776. PubMed ID: 28749925
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C care cascade among patients with and without tuberculosis: Nationwide observational cohort study in the country of Georgia, 2015-2020.
Baliashvili D; Blumberg HM; Gandhi NR; Averhoff F; Benkeser D; Shadaker S; Gvinjilia L; Turdziladze A; Tukvadze N; Chincharauli M; Butsashvili M; Sharvadze L; Tsertsvadze T; Zarkua J; Kempker RR
PLoS Med; 2023 May; 20(5):e1004121. PubMed ID: 37141386
[TBL] [Abstract][Full Text] [Related]
6. Progress in Testing for and Treatment of Hepatitis C Virus Infection Among Persons Who Inject Drugs - Georgia, 2018.
Stvilia K; Spradling PR; Asatiani A; Gogia M; Kutateladze K; Butsashvili M; Zarkua J; Tsertsvadze T; Sharvadze L; Japaridze M; Kuchuloria T; Gvinjilia L; Tskhomelidze I; Gamkrelidze A; Khonelidze I; Sergeenko D; Shadaker S; Averhoff F; Nasrullah M
MMWR Morb Mortal Wkly Rep; 2019 Jul; 68(29):637-641. PubMed ID: 31344021
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse.
Lamoury FMJ; Soker A; Martinez D; Hajarizadeh B; Cunningham EB; Cunningham P; Bruggmann P; Foster GR; Dalgard O; Backmund M; Conway B; Robaeys G; Swan T; Cloherty G; Marks P; Grebely J; Dore GJ; Applegate TL
J Clin Virol; 2017 Jul; 92():32-38. PubMed ID: 28521211
[TBL] [Abstract][Full Text] [Related]
8. Trends in hepatitis C virus coinfection and its cascade of care among adults living with HIV in Asia between 2010 and 2020.
Ross J; Rupasinghe D; Avihingsanon A; Lee MP; Pujari S; Sharp G; Kumarasamy N; Khusuwan S; Khol V; Agus Somia IK; Pham TN; Kiertiburanakul S; Choi JY; Duy Do C; Sohn AH; Jiamsakul A;
PLoS One; 2023; 18(6):e0287909. PubMed ID: 37379314
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C prevalence and risk factors in Georgia, 2015: setting a baseline for elimination.
Hagan LM; Kasradze A; Salyer SJ; Gamkrelidze A; Alkhazashvili M; Chanturia G; Chitadze N; Sukhiashvili R; Shakhnazarova M; Russell S; Blanton C; Kuchukhidze G; Baliashvili D; Hariri S; Ko S; Imnadze P; Drobeniuc J; Morgan J; Averhoff F
BMC Public Health; 2019 May; 19(Suppl 3):480. PubMed ID: 32326913
[TBL] [Abstract][Full Text] [Related]
10. Screening and linkage to care for hepatitis C among inpatients in Georgia's national hospital screening program.
Shadaker S; Nasrullah M; Gamkrelidze A; Ray J; Gvinjilia L; Kuchuloria T; Butsashvili M; Getia V; Metreveli D; Tsereteli M; Tsertsvadze T; Link-Gelles R; Millman AJ; Turdziladze A; Averhoff F
Prev Med; 2020 Sep; 138():106153. PubMed ID: 32473265
[TBL] [Abstract][Full Text] [Related]
11. Improved Hepatitis C Cure Cascade Outcomes Among Urban Baby Boomers in the Direct-Acting Antiviral Era.
Dupont SC; Fluker SA; Quairoli KM; Body C; Okosun I; Lom J; Miller LS
Public Health Rep; 2020 Jan; 135(1):107-113. PubMed ID: 31756116
[TBL] [Abstract][Full Text] [Related]
12. Interim effect evaluation of the hepatitis C elimination programme in Georgia: a modelling study.
Walker JG; Kuchuloria T; Sergeenko D; Fraser H; Lim AG; Shadaker S; Hagan L; Gamkrelidze A; Kvaratskhelia V; Gvinjilia L; Aladashvili M; Asatiani A; Baliashvili D; Butsashvili M; Chikovani I; Khonelidze I; Kirtadze I; Kuniholm MH; Otiashvili D; Sharvadze L; Stvilia K; Tsertsvadze T; Zakalashvili M; Hickman M; Martin NK; Morgan J; Nasrullah M; Averhoff F; Vickerman P
Lancet Glob Health; 2020 Feb; 8(2):e244-e253. PubMed ID: 31864917
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of hepatitis C virus in adult population in the Czech Republic - time for birth cohort screening.
Chlibek R; Smetana J; Sosovickova R; Gal P; Dite P; Stepanova V; Pliskova L; Plisek S
PLoS One; 2017; 12(4):e0175525. PubMed ID: 28406947
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of alcohol use behavior among patients cured through HCV elimination program in Georgia.
Butsashvili M; Gulbiani L; Kanchelashvili G; Kamkamidze T; Kajaia M; Gudavadze S; Kamkamidze G
BMC Res Notes; 2024 Jun; 17(1):160. PubMed ID: 38858781
[TBL] [Abstract][Full Text] [Related]
15. Decentralised same day test and treatment of hepatitis C levering existing peer support networks among men who inject drugs: feasibility and effectiveness.
Rajkumar N; Khumukcham LS; Thangjam D; Singh S; Khwairakpam G; Shilton S; Goel A
Harm Reduct J; 2024 May; 21(1):98. PubMed ID: 38769517
[TBL] [Abstract][Full Text] [Related]
16. Determination of serum hepatitis C virus (HCV) core protein using a novel approach for quantitative evaluation of HCV viraemia in anti-HCV-positive patients.
Komatsu F; Takasaki K
Liver; 1999 Oct; 19(5):375-80. PubMed ID: 10533794
[TBL] [Abstract][Full Text] [Related]
17. Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia: results of hepatology clinic HEPA experience.
Dolmazashvili E; Abutidze A; Chkhartishvili N; Karchava M; Sharvadze L; Tsertsvadze T
Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1223-1230. PubMed ID: 28857900
[TBL] [Abstract][Full Text] [Related]
18. Identification and Clinical Management of Persons with Chronic Hepatitis C Virus Infection - Cherokee Nation, 2012-2015.
Mera J; Vellozzi C; Hariri S; Carabin H; Drevets DA; Miller A; Reilley B; Essex W; Gahn D; Lyons L; Leston J; Ward JW
MMWR Morb Mortal Wkly Rep; 2016 May; 65(18):461-6. PubMed ID: 27172175
[TBL] [Abstract][Full Text] [Related]
19. High-Yield Birth-Cohort Hepatitis C Virus Screening and Linkage to Care Among Underserved African Americans, Atlanta, Georgia, 2012-2013.
Miller LS; Rollin F; Fluker SA; Lundberg KL; Park B; Quairoli K; Niyibizi NK; Spaulding AC
Public Health Rep; 2016; 131 Suppl 2(Suppl 2):84-90. PubMed ID: 27168666
[TBL] [Abstract][Full Text] [Related]
20. ELIMINATE: a PCR record-based macroelimination project for systematic recall of HCV-RNA-positive persons in Austria.
Schwarz C; Bauer D; Dorn L; Jachs M; Hartl L; Chromy D; Weseslindtner L; Pfisterer N; Hennlich B; Stückler A; Strassl R; Voill-Glaninger A; Hübl W; Willheim M; Köhrer K; Jansen-Skoupy S; Tomez S; Krugluger W; Madl C; Schwarz M; Balcar L; Semmler G; Brinkmann L; Burghart L; Antonitsch L; Weidinger G; Riedl F; Laferl H; Kurteva V; Traugott M; Hind J; Wenisch C; Aburaia A; Sebesta C; Schmid D; Rothweiler S; Remetic J; Gschwantler M; Maieron A; Reiberger T
Wien Klin Wochenschr; 2024 May; 136(9-10):278-288. PubMed ID: 37773541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
